Methodology of OTA's report on drug labeling in developing countries.
This article discusses the methodology of the OTA Project on Drug Labeling in Developing Countries. This report describes (a) the process of the project; (b) observations from a field visit to Thailand; (c) the development of the multinational pharmaceutical industry; and (d) influences on multinational pharmaceutical companies from their home countries, host countries, international organizations, self-regulation, and public interest groups. The results of the assessment will appear in the final report to Congress.
Gelband
H
H
OTA Health Program, Washington, DC 20003.
Corrigan
J
J
McDonough
R
R
D003254:Consumer Advocacy; D003906:Developing Countries; D004345:Drug Industry / Q000331:legislation & jurisprudence; D004348:Drug Labeling / Q000379:methods*; D004335:Drug and Narcotic Control; D013673:Technology Assessment, Biomedical; D013785:Thailand; D014481:United States; D014491:United States Office of Technology Assessment